Human PEX2 activation kit by CRISPRa

CAT#: GA103963

PEX2 CRISPRa kit - CRISPR gene activation of human peroxisomal biogenesis factor 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit polyclonal anti-PXMP3 antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


PEX2 (Myc-DDK-tagged)-Human peroxisomal biogenesis factor 2 (PEX2), transcript variant 1
    • 10 ug

CNY 2,400.00
CNY 4,180.00


PEX2 Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol PEX2
Locus ID 5828
Kit Components

GA103963G1, PEX2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA103963G2, PEX2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA103963G3, PEX2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_000318, NM_001079867, NM_001172086, NM_001172087
Synonyms PAF1; PBD5A; PBD5B; PMP3; PMP35; PXMP3; RNF72; ZWS3
Summary This gene encodes an integral peroxisomal membrane protein required for peroxisome biogenesis. The protein is thought to be involved in peroxisomal matrix protein import. Mutations in this gene result in one form of Zellweger syndrome and infantile Refsum disease. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...